Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Men with type 2 diabetes and cardiovascular risk focus of study.
Read More »Can Testosterone Decrease Your Cardiac Biomarkers?
Victoza LEADER Trial Top-Line Results Announced
Victoza LEADER trial of 9,000 adults with type 2 diabetes found that drug significantly reduced the risk of heart attack or stroke.
Read More »Chlorthalidone Superior for Hypertension
New study shows medication superior to HCTZ when lowering blood pressure in patients.
Read More »Does Physical Fitness Prevent Heart Attacks?
New study examines cardiovascular impact of higher levels of exercise.
Read More »Diabetes for Cardiologists Part 11
In this week's Homerun Slides, targets and therapies for type 2 diabetes based on patient characteristics and A1C.
Read More »Diabetes for Cardiologists Part 10
In this week's Homerun Slides, EMPA-REG trial results and implications.
Read More »Long-Term Diabetes Predicting The Risk of Stroke
New research shows duration a greater predictor than glycemic control or A1C.
Read More »ED + DM = CAD
Endothelial dysfunction is the link between ED, DM, and CAD.
Read More »Diabetes for Cardiologists Part 9
In this week's Homerun Slides, surprising information about SGLT-2 inhibitors.
Read More »Alogliptin Prevents the Progression of Atherosclerosis in Type 2 Diabetes Patients
New study suggests possible role for DPP-4 inhibitor in reducing CVD risk.
Read More »